The two opposing head coaches that have lost to the Syracuse University men’s lacrosse team this season have both anointed ...

Syracuse Lacrosse defeated Vermont 13-5 on Friday night. Here's what players and coaches had to say during the presser.

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

MedRhythms, Inc. today announced that Joel Behnke has been hired as Chief Commercial Officer. Mr. Behnke brings over two decades of commercial leadership in medical devices to MedRhythms where he will ...

Using proper running form can help prevent injuries while boosting efficiency and improving performance. Here's what you need ...

Enobosarm demonstrated a statistically significant benefit in preserving lean mass in patients with overweight or obesity undergoing treatment with semaglutide.Topline results from the Phase ...

The PoNS device led to sustained benefits in gait function in people with multiple sclerosis in a real-world study.

NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $3.84 million, announced significant findings from the PoNS Therapeutic Experience ...

“Walking gait’s got swag but we need these robots to go firefighting [as soon as possible],” said Fan, emphasizing the robot’s potential beyond mere technological display. Last Octob ...

Palestinians react to Trump saying US will 'take over' Gaza ...